Boston Scientific BSX has put up double-digit sales and profit growth figures every quarter for at least the last two years.

The National Consumer Commission has urgently recalled specific Boston Scientific Encore medical devices after contamination ...

Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

Boston Scientific has updated the instructions for use for products deployed in the implantation of its Watchman heart device ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.

Boston Scientific improved B2B search experiences by integrating AI-enabled search from Coveo into their SAP Commerce Cloud stack.

Boston Scientific on Thursday agreed to sell its neurovascular business to Stryker for $1.5 billion in cash, as the medical devices maker seeks to focus on core operations. By Dealbook Oct. 28, 2010 ...